专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07119195B2 Pharmaceutically acceptable starch 失效
公开(公告)号：US07119195B2
公开(公告)日：2006-10-10
申请号：US10627920
申请日：2003-07-28
申请人： Nils Ove Gustavsson , Monica Jönsson , Per Berdén , Timo Laakso
发明人： Nils Ove Gustavsson , Monica Jönsson , Per Berdén , Timo Laakso
IPC分类号： C08B31/00 , A61K31/717
CPC分类号： A61K9/1652 , C08B30/04 , C08B30/12 , Y10T428/2982 , Y10T428/2991
摘要： Production of purified, parenterally administrable starch by washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, dissolving the starch in aqueous medium, molecular weight reduction by shearing, and optionally removal of residual water-soluble proteins, preferably by anion exchange chromatography.Purified starch and microparticles based on such starch.

2. 发明授权

US06616948B2 Starch 失效
标题翻译：淀粉
公开(公告)号：US06616948B2
公开(公告)日：2003-09-09
申请号：US09970795
申请日：2001-10-05
申请人： Nils Ove Gustavsson , Monica Jönsson , Per Berdén , Timo Laakso , Mats Reslow
发明人： Nils Ove Gustavsson , Monica Jönsson , Per Berdén , Timo Laakso , Mats Reslow
IPC分类号： A61K950
CPC分类号： A61K9/1652 , C08B30/04 , C08B30/12 , Y10T428/2982 , Y10T428/2991
摘要： Production of purified, parenterally administrable starch by washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, subjecting the starch to a molecular weight reduction by acid hydrolysis, and optionally removing residual water-soluble proteins. Purified starch and microparticles based on such starch.
摘要翻译：通过洗涤含有超过85％的支链淀粉的淀粉来制备纯化的，肠胃外可施用的淀粉，以去除表面定位的蛋白质，脂质和内毒素，通过酸水解使淀粉进行分子量降低，并任选地除去残留的水溶性蛋白质。基于这种淀粉的纯化淀粉和微粒。

3. 发明授权

US06689389B2 Pharmaceutically acceptable starch 失效
标题翻译：药学上可接受的淀粉
公开(公告)号：US06689389B2
公开(公告)日：2004-02-10
申请号：US09970648
申请日：2001-10-05
申请人： Nils Ove Gustavsson , Monica Jönsson , Per Berdén , Timo Laakso , Mats Reslow
发明人： Nils Ove Gustavsson , Monica Jönsson , Per Berdén , Timo Laakso , Mats Reslow
IPC分类号： A61K950
CPC分类号： A61K9/1652 , C08B30/04 , C08B30/12 , Y10T428/2982 , Y10T428/2991
摘要： Production of purified, parenterally administrable starch by washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, dissolving the starch in aqueous medium, molecular weight reduction by shearing, and optionally removal of residual water-soluble proteins, preferably by anion exchange chromatography. Purified starch and microparticles based on such starch.
摘要翻译：通过洗涤含有超过85％的支链淀粉的淀粉来生产纯化的，肠胃外可给予的淀粉，以去除表面定位的蛋白质，脂质和内毒素，将淀粉溶解在水性介质中，通过剪切分解重量减少和任选地除去残留的水溶性蛋白质，优选通过阴离子交换色谱法。基于这种淀粉的纯化淀粉和微粒。

4. 发明授权

US07033609B2 Microparticle preparation 失效
公开(公告)号：US07033609B2
公开(公告)日：2006-04-25
申请号：US09970792
申请日：2002-01-10
申请人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow , Sören Björn , Jörn Drustrup
发明人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow , Sören Björn , Jörn Drustrup
IPC分类号： A61F9/50 , B01J13/02 , B32B15/02
CPC分类号： A61K38/17 , A61K9/1652 , A61K38/27 , Y10T428/2982 , Y10T428/2991
摘要： A parenterally administrable, biodegradable microparticle preparation containing a biologically active substance which, during the first 24 hours after injection, exhibits a release of the active substance that is less than 25% of the total release, determined from a concentration-time curve in the form of the ratio between the area under the curve during the said first 24 hours and the total area under the curve in question

5. 发明授权

US06706288B2 Microparticles 失效
标题翻译：微粒
公开(公告)号：US06706288B2
公开(公告)日：2004-03-16
申请号：US09970793
申请日：2001-10-05
申请人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow
发明人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow
IPC分类号： A61K950
CPC分类号： A61K9/1623 , A61K9/1652 , A61K9/1694 , A61K9/5031 , A61K9/5073 , A61K38/00 , B01J13/02 , B01J13/22 , Y10T428/2982 , Y10T428/2991
摘要： A process for producing parenterally administrable microparticles, in which an at least 20% by weight aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active substance, an emulsion of starch droplets is formed in an outer phase of polymer solution, the starch droplets are made to gel, and the gelled starch particles are dried. A release-controlling shell is optionally also applied to the particles. Microparticles which essentially consist of said starch, have an amino acid content of less than 50 &mgr;g and have no covalent chemical cross-linking.
摘要翻译：制备肠胃外给药的微粒的方法，其中制备分子量降低的至少20重量％的纯化支链淀粉基淀粉水溶液，该溶液与生物活性物质组合，淀粉液滴的乳液形成于聚合物溶液的外相，淀粉液滴凝胶化，凝胶化淀粉颗粒干燥。释放控制壳任选也被施加到颗粒上。基本上由所述淀粉组成的微粒的氨基酸含量小于50杯，并且没有共价的化学交联。

6. 发明授权

US07105181B2 Microparticles 失效
公开(公告)号：US07105181B2
公开(公告)日：2006-09-12
申请号：US10705204
申请日：2003-11-10
申请人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow
发明人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow
IPC分类号： A61K9/50 , B01J13/02 , B32B15/02
CPC分类号： A61K9/0024 , A61K9/1652 , A61K9/1694 , A61K9/5031 , A61K38/00 , Y10T428/2982 , Y10T428/2991
摘要： A process for producing parenterally administrable microparticles, in which an at least 20% by weight aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active substance, an emulsion of starch droplets is formed in an outer phase of polymer solution, the starch droplets are made to gel, and the gelled starch particles are dried. A release-controlling shell is optionally also applied to the particles.Microparticles which essentially consist of said starch, have an amino acid content of less than 50 μg and have no covalent chemical cross-linking.

7. 发明授权

US06692770B2 Starch microparticles 失效
标题翻译：淀粉微粒
公开(公告)号：US06692770B2
公开(公告)日：2004-02-17
申请号：US10461445
申请日：2003-06-16
申请人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow
发明人： Nils Ove Gustavsson , Monica Jönsson , Timo Laakso , Mats Reslow
IPC分类号： A61K916
CPC分类号： A61K9/1623 , A61K9/1652 , A61K9/1694 , A61K9/5031 , A61K9/5073 , A61K38/00 , B01J13/02 , B01J13/22 , Y10T428/2982 , Y10T428/2991
摘要： A process for producing parenterally administrable microparticles, in which an at least 20% by weight aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active substance, an emulsion of starch droplets is formed in an outer phase of polymer solution, the starch droplets are med to gel, and the gelled starch particles are dried. A release-controlling shell is optionally also applied to the particles. Microparticles which essentially consist of said starch, have an amino acid content of less than 50 &mgr;g and have no covalent chemical cross-linking.
摘要翻译：制备肠胃外给药的微粒的方法，其中制备分子量降低的至少20重量％的纯化支链淀粉基淀粉水溶液，该溶液与生物活性物质组合，淀粉液滴的乳液形成于聚合物溶液的外相，淀粉液滴被凝胶化，凝胶化的淀粉颗粒被干燥。释放控制壳任选地也施加到颗粒上。基本上由所述淀粉组成的微粒的氨基酸含量小于50杯，并且没有共价的化学交联。

8. 发明授权

US06616949B2 Process for producing microparticles 失效
公开(公告)号：US06616949B2
公开(公告)日：2003-09-09
申请号：US09970796
申请日：2001-10-05
申请人： Monica Jönsson , Timo Laakso , Mats Reslow
发明人： Monica Jönsson , Timo Laakso , Mats Reslow
IPC分类号： B01J1302
CPC分类号： A61K9/5089 , Y10T428/2985
摘要： A process for producing microparticles containing biologically active substance, in which process an aqueous solution of the said substance is prepared, this solution is mixed with an aqueous solution of PEG such that the substance is concentrated and/or solidified, the substance is optionally washed, the substance is mixed with an organic polymer solution, the composition obtained is mixed, after the admixture of said polymer solution, with an aqueous polymer solution, thereby forming an emulsion of droplets of first mentioned polymer as the internal phase, said droplets are solidified into microparticles, the microparticles are dried and a release-controlling shell is optionally applied to these.

9. 发明授权

US06936278B2 Microparticles 失效
标题翻译：微粒
公开(公告)号：US06936278B2
公开(公告)日：2005-08-30
申请号：US10162674
申请日：2002-06-06
申请人： Mats Reslow , Monica Jönsson , Karin Larsson , Timo Laakso
发明人： Mats Reslow , Monica Jönsson , Karin Larsson , Timo Laakso
IPC分类号： A61K9/50 , A61F2/00 , A61F13/00 , A61K9/14 , A61K9/16
CPC分类号： A61K9/5073
摘要： A process for producing microparticles, in which an aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active substance, an emulsion of starch droplets is formed in an outer phase of polymer solution, the starch droplets are made to gel, the gelled starch particles are dried, and a release-controlling shell is optionally applied to the particles, wherein at least one buffer substance having the ability of keeping the pH of the produced microparticles above 3 if exposing the microparticles to an aqueous evironment is added at any stage during the process.Microparticles which essentially consist of said starch, have an amino acid content of less than 50 μg and have no covalent chemical cross-linking and which have the aktivity of keeping the pH above 3 if exposed to a aqueous environment.
摘要翻译：制备微粒的方法，其中制备了分子量降低的纯化支链淀粉基淀粉的水溶液，该溶液与生物活性物质组合，在聚合物溶液的外相中形成淀粉液滴的乳液，淀粉使凝胶凝胶化，凝胶化淀粉颗粒被干燥，并且任选地将颗粒释放控制壳，其中至少一种缓冲物质，如果将微粒暴露于所述微粒上，则具有将所产生的微粒的pH保持在3以上的能力在该过程的任何阶段加入水性环境。基本上由所述淀粉组成的微粒具有小于50mug的氨基酸含量并且没有共价的化学交联，并且如果暴露于水性环境中，其具有保持pH高于3的活性。

10. 发明申请

US20100180464A1 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture 审中-公开
标题翻译：适用于肠胃外给药的核心和微胶囊以及其制造方法
公开(公告)号：US20100180464A1
公开(公告)日：2010-07-22
申请号：US12596180
申请日：2008-04-18
申请人： Timo Laakso , Monica Joennson
发明人： Timo Laakso , Monica Joennson
IPC分类号： F26B5/06
CPC分类号： A61K9/1652 , A61K9/1694
摘要： The present invention relates to novel processes for the manufacture of cores of a specific polymer and a biologically active substance, and of such cores carrying a shell, i.e. microcapsules, to the cores and microcapsules thus produced, and to a pharmaceutical composition comprising such microcapsules.
摘要翻译：本发明涉及用于制造特定聚合物和生物活性物质的核心的这些新颖方法，以及将由此产生的核心和微胶囊携带壳（即微胶囊）的这种核心以及包含这种微胶囊的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式